Latest News

Vials and Syringe on White Table with Background Windows Stock Photo | ©
Secukinumab Found Cost-Effective for Patients With Moderate to Severe Psoriasis

September 28th 2023

Compared with other biologics frequently used in China for moderate-to-severe psoriasis, secukinumab is the most cost-effective treatment option.

Japan flag in Tokyo | Image credit: Savvapanf Photo © -
Alvotech’s Stelara Biosimilar Approved in Japan

September 25th 2023

globe and an atom
Regulatory Updates From Around the Globe Provide Hope for Biosimilars

September 9th 2023

doctor filling syringe | natali_mis -
The Growth of Biosimilars Continues to Create Hope for Lower Drug Costs

September 7th 2023

businessmen shaking hands
CVS Launches New Biosimilars Brand

September 6th 2023

Video Interviews
CFB podcast banner

More News

© 2023 MJH Life Sciences

All rights reserved.